Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine-cisplatin and high dose-intensity MVAC.
Yongjune LeeYoung Seok KimBumsik HongYong Mee ChoJae Lyun LeePublished in: Journal of cancer research and clinical oncology (2021)
Oncologic outcomes were not significantly different between the GC and HD MVAC when used as NAC in MIBC/UTUC.